Table 3.
Reproduction Numbera | Immunity Threshold | Critical Coverage of Vaccination | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
VE 95% | VE 80% | VE 50% | ||||||||
HPV Type | Girls and Boys | Girls | Girls and Boys | Girls | Girls and Boys | Girls | Girls and Boys | Girls | Girls and Boys | Girls |
HPV16 | 3.3 | 10 | 70% | 90% | 74% | 95% | 88% | NEb | NEb | NEb |
HPV18 | 2.2 | 4.5 | 55% | 78% | 58% | 82% | 69% | 98% | NEb | NEb |
HPV31/33 | 1.7 | 2.9 | 40% | 65% | 42% | 68% | 50% | 81% | 80% | NEb |
HPV45 | 1.7 | 2.9 | 40% | 65% | 42% | 68% | 50% | 81% | 80% | NEb |
HPV35 | 1.3 | 1.5 | 20% | 35% | 21% | 37% | 25% | 44% | 40% | 70% |
Abbreviations: NE, no eradication; VE, vaccine efficacy.
aReproduction number (R0) is calculated by determining the immunity threshold using the transmission model with a computational vaccine with 100% efficacy. In the gender-neutral vaccination strategy (girls and boys), R0 is from girls/boys to boys/girls. In the girls-only vaccination strategy (girls) R0 is from girls to girls (via boys, heterosexual model).
bNE = no eradication even with a 100% coverage of vaccination.